Monash University: Drug repurposing is no panacea in race to treat COVID-19
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls…
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls…
Distinct immune response identified in the early phase of SARS CoV-2 infection: Infection with the SARS-CoV-2 virus leads to a…
Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to…
Hope of tackling health inequalities relies on action across government: Commenting on the letter sent to the Prime Minister from…
Computer simulations showing how patients and staff move around inside hospitals are helping civil engineers make modifications to help control…
Vaccine passports linked to COVID-19 vaccine hesitancy in UK and Israel: A new study from Imperial College London has found…
How can we manage the inevitable rise of common childhood illnesses as kids go back to school? Dr Punam Krishan,…
Supporting back to school anxiety in a time of COVID: Dr Hayley van Zwanenberg is a Consultant Child and Adolescent…
Moving towards digital documentation of COVID-19 status: Vaccination certificates are nothing new. They are health documents that record a vaccination…
Researchers discover control mechanism for melanoma skin cancer: How the intricacies of tissue memory T cells could be the future…
This website uses cookies.